Exonhit Therapeutics SA, which is developing therapies and diagnostics for cancer and Alzheimer’s disease, has appointed Isabelle Barber, to its management board. She is an executive vice president of the French company’s diagnostics division and has specialist knowledge of molecular diagnostics.
Copyright 2011 Evernow Publishing Ltd